You have 1 action to finish to complete your account. Customize your experience by selecting your interests on the Personalization page
Rhinology
When is the right time to consider a biologic in patients with CRSwNP?
Prof. Hellings and Prof. Corso explain that the right time to implement a biologic depends on academic and reimbursement criteria, which vary by country.
MD, PhD
Peter Hellings
Learning objectives
- Understand and evaluate the academic and reimbursement criteria for prescribing biologics, which vary significantly across different countries
- Recognize the potential benefits of early biologic intervention in the disease process, while considering the current limitations and regulations that may require prior surgical procedures
Description
The right time to implement a biologic depends on academic and reimbursement criteria, which vary by country. Early intervention may be beneficial, but in many countries, prescribing a biologic require prior surgeries. Future developments may allow earlier prescriptions.
Tags
MAT-GLB-2402325 - 1.0 - 05/2024
About this expert
Rhinology
Peter Hellings
MD, PhD
Professor and Clinic Head of the Department of Otorhinolaryngology | University Hospitals of Leuven, Belgium
See author’s profileRelated resources
